Skip to main content
. 2025 Jul 14;26(14):6755. doi: 10.3390/ijms26146755
ODN oligodeoxynucleotides
OVA ovalbumin
CpG cytosine-phosphate-guanine
AIC immunotherapy
Treg regulatory T cells
um-V2 unmethylated CpG oligodeoxynucleotide
2m-V1 CpG oligodeoxynucleotide incorporating two 5-methylcytosines at positions 4 and 12
2m’-V3 CpG oligodeoxynucleotide with two 5-methylcytosines shifted at positions 7 and 15
3m-V4 CpG oligodeoxynucleotide with an extended backbone structure, with three 5-methylcytosines at positions 3, 11 and 19